Cipher Pharmaceuticals Inc.
CPHRF
$9.01
$0.06040.68%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -43.36% | -51.08% | -19.36% | -16.35% | -23.48% |
| Total Depreciation and Amortization | 227.38% | 114.59% | -17.67% | -0.34% | 24.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -115.42% | 98.94% | 75.08% | 71.45% | 83.16% |
| Change in Net Operating Assets | 373.29% | -375.99% | -42.35% | -349.06% | -7.98% |
| Cash from Operations | 22.17% | -12.50% | 29.29% | 2.46% | 49.17% |
| Capital Expenditure | -55,486.11% | -- | -98.77% | -85.19% | -77.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -55,486.11% | -- | -98.77% | -85.19% | -77.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -109.91% | -101.01% | -19.61% | -40.74% | -98.21% |
| Issuance of Common Stock | -64.32% | 21.09% | 180.37% | 156.04% | 222.73% |
| Repurchase of Common Stock | 96.83% | -691.15% | -562.87% | -331.96% | -179.63% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 849.35% | 7,118.13% | -572.05% | -338.93% | -174.27% |
| Foreign Exchange rate Adjustments | -307.94% | -46.41% | 17.82% | 143.33% | 185.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -300.09% | -322.89% | -4.12% | -26.11% | 32.59% |